Richard M Goldberg Selected Research

Edrecolomab

5/2013	Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.
8/2011	Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581.
6/2005	Lessons learned from the edrecolomab story: how a checkered past became a checkered flag for monoclonal antibodies in colorectal cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard M Goldberg Research Topics

Disease

140	Neoplasms (Cancer) 01/2022 - 01/2002
114	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2002
66	Colonic Neoplasms (Colon Cancer) 01/2022 - 04/2002
19	Leukemia 11/2020 - 11/2005
17	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2004
17	Adenocarcinoma 12/2020 - 01/2002
16	Microsatellite Instability 11/2020 - 07/2003
13	Neutropenia 01/2021 - 01/2002
13	Carcinoma (Carcinomatosis) 04/2017 - 01/2002
12	Pancreatic Neoplasms (Pancreatic Cancer) 04/2015 - 04/2003
9	Nausea 01/2021 - 04/2003
9	Disease Progression 11/2020 - 01/2007
8	Diarrhea 01/2021 - 01/2004
7	Rectal Neoplasms (Rectal Cancer) 01/2018 - 03/2005
6	Vomiting 01/2021 - 04/2003
4	Thrombocytopenia (Thrombopenia) 01/2021 - 04/2003
4	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 01/2007
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2018 - 10/2003
4	Fatigue 01/2013 - 06/2005
3	Hypertension (High Blood Pressure) 01/2021 - 01/2013
3	Leukopenia 01/2021 - 08/2004
3	Febrile Neutropenia 01/2018 - 01/2004
3	Turcot syndrome 01/2018 - 06/2015
3	Exanthema (Rash) 01/2013 - 06/2005
2	Stomatitis 01/2021 - 01/2005
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 11/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2015 - 10/2007
2	Peritoneal Neoplasms 01/2012 - 06/2011
2	Liver Diseases (Liver Disease) 05/2011 - 03/2009
2	Hemorrhage 08/2010 - 07/2009

Drug/Important Bio-Agent (IBA)

74	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 03/2002
54	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 08/2002
44	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 01/2002
44	Leucovorin (Folinic Acid)FDA Link 01/2021 - 10/2003
27	Cetuximab (Erbitux)FDA Link 01/2021 - 11/2004
26	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2005
18	Proteins (Proteins, Gene)FDA Link 11/2020 - 02/2002
17	Bevacizumab (Avastin)FDA Link 11/2020 - 06/2004
16	Gemcitabine FDA Link 04/2015 - 01/2003
13	Biological ProductsIBA 01/2020 - 12/2005
12	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 06/2006
12	Monoclonal AntibodiesIBA 02/2018 - 05/2005
9	Immune Checkpoint InhibitorsIBA 01/2022 - 06/2015
8	ErbB Receptors (EGF Receptor)IBA 01/2019 - 10/2003
7	Sodium Glutamate (Accent)IBA 11/2021 - 10/2007
7	Cisplatin (Platino)FDA LinkGeneric 11/2017 - 04/2003
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015 - 10/2004
5	regorafenibIBA 10/2020 - 01/2013
5	Pharmaceutical PreparationsIBA 02/2018 - 04/2006
4	hydroxide ionIBA 10/2021 - 04/2011
4	Vitamin D FDA LinkGeneric 10/2021 - 04/2011
4	Formaldehyde (Formol)FDA Link 11/2018 - 05/2013
4	ParaffinIBA 11/2018 - 03/2009
4	Codon (Codons)IBA 04/2017 - 10/2013
4	Carboplatin (JM8)FDA LinkGeneric 01/2015 - 08/2002
4	Panitumumab (Vectibix)FDA Link 07/2014 - 12/2009
4	Levamisole (Decaris)FDA Link 07/2007 - 05/2004
3	B7-H1 AntigenIBA 01/2022 - 01/2019
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2021 - 10/2003
3	pembrolizumabIBA 11/2018 - 06/2015
3	LigandsIBA 02/2018 - 12/2005
3	BilirubinIBA 01/2018 - 06/2006
3	Thymidylate SynthaseIBA 01/2017 - 04/2002
3	Antineoplastic Agents (Antineoplastics)IBA 12/2016 - 01/2002
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 10/2007
3	EdrecolomabIBA 05/2013 - 06/2005
2	thiamine triphosphorate (TTP)IBA 01/2022 - 06/2011
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 12/2016
2	Calcibiotic Root Canal SealerIBA 10/2021 - 01/2020
2	AdiponectinIBA 10/2021 - 01/2021
2	25-hydroxyvitamin DIBA 10/2021 - 12/2019
2	Capecitabine (Xeloda)FDA Link 01/2021 - 05/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2015
2	RNA (Ribonucleic Acid)IBA 11/2020 - 01/2016
2	Calcifediol (Calcidiol)FDA Link 07/2019 - 04/2011
2	Angiogenesis InhibitorsIBA 01/2019 - 12/2005
2	NivolumabIBA 11/2018 - 02/2018
2	Epirubicin (Ellence)FDA LinkGeneric 11/2017 - 10/2016
2	Carcinoembryonic AntigenIBA 10/2017 - 01/2008
2	AntibodiesIBA 01/2017 - 01/2011
2	folfirinoxIBA 04/2015 - 01/2013
2	Transaminases (Aminotransferases)IBA 06/2013 - 06/2005
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2013 - 07/2011
2	Docetaxel (Taxotere)FDA Link 11/2009 - 01/2002
2	Insulin-Like PeptidesIBA 12/2008 - 06/2005
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 12/2008 - 06/2005
2	C-PeptideIBA 12/2008 - 06/2005
2	Insulin-Like Growth Factor I (IGF-1)IBA 12/2008 - 06/2005

Therapy/Procedure

81	Therapeutics 01/2022 - 01/2002
76	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
31	Adjuvant Chemotherapy 10/2021 - 04/2002
12	Radiotherapy 11/2017 - 04/2003
8	Immunotherapy 01/2022 - 01/2008
8	Combination Drug Therapy (Combination Chemotherapy) 10/2013 - 11/2002
5	Neoadjuvant Therapy 12/2017 - 01/2004
4	Biological Therapy 12/2019 - 01/2007
3	Chemoradiotherapy 11/2017 - 03/2011
3	Folfox protocol 04/2012 - 01/2004
2	Continuity of Patient Care 01/2018 - 01/2007
2	Combined Modality Therapy 03/2011 - 07/2008